by Kelli Jones | Jul 24, 2018 | Featured
When Arushi Raval was 12, her childhood friend, Kuhu Basak, was diagnosed with brain cancer. Surgeons were able to remove 30 percent of Basak’s tumor. This was followed by six weeks of proton radiation therapy, but the tumor grew back. She has gone through multiple...
by Garth Sundem | Dec 29, 2017 | Featured, Latest News, Research
Clinical trials of new anti-cancer therapies have often excluded patients whose disease has spread to the brain or central nervous system (CNS) or, if such patients were allowed on trial, trials have often failed to clearly capture information on the drug’s effect in...
by Garth Sundem | Dec 19, 2017 | Latest News, Research
Although targeted therapies have produced dramatic advances in our ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem. Radiation is often used to treat deposits in the brain, but the best technique to...
by Garth Sundem | Jan 25, 2017 | Latest News, Research
About 10 percent of lung cancers in the United States and as many as 40 percent in Asia are driven by mutations in the EGFR gene. EGFR targeted treatment advances over the previous decade now result in multiple options for controlling the disease in the body, but due...
by Garth Sundem | Jan 17, 2017 | Featured, Latest News, Patient Care
After her brain cancer became resistant to chemotherapy and then to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months to live. Now a paper published January 17 in the journal eLife describes a new drug combination that has...
